Title |
Combined vitamin B6‐magnesium treatment in autism spectrum disorder
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2005
|
DOI | 10.1002/14651858.cd003497.pub2 |
Pubmed ID | |
Authors |
Chad Nye, Alejandro Brice |
Abstract |
The use of mega-vitamin intervention began in the 1950s with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with "autism syndrome" when speech and language improvement was observed in some children as a result of large doses of B6. A number of studies attempted to assess the effects of vitamin B6-Magnesium (Mg) was found to reduce undesirable side effects from B6) on characteristics such as verbal communication, non-verbal communication, interpersonal skills, and physiological function, in individuals with autism. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 3 | 19% |
Canada | 2 | 13% |
Nigeria | 1 | 6% |
United States | 1 | 6% |
Unknown | 9 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 16 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 224 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 28 | 12% |
Student > Bachelor | 26 | 12% |
Researcher | 23 | 10% |
Student > Ph. D. Student | 19 | 8% |
Other | 17 | 8% |
Other | 58 | 26% |
Unknown | 54 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 28% |
Psychology | 28 | 12% |
Nursing and Health Professions | 17 | 8% |
Social Sciences | 12 | 5% |
Agricultural and Biological Sciences | 9 | 4% |
Other | 37 | 16% |
Unknown | 59 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2023.
All research outputs
#1,033,148
of 25,605,018 outputs
Outputs from Cochrane database of systematic reviews
#2,061
of 13,148 outputs
Outputs of similar age
#1,342
of 71,086 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 55 outputs
Altmetric has tracked 25,605,018 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,148 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 71,086 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.